B

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Operator Biological Manufacturing USP

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeKöniz, SwitzerlandNo salary listedIn-person

About the Job

Requirements

  • Completed vocational apprenticeship in the food or pharmaceutical sector, or relevant professional experience.
  • Professional experience in cleanrooms under GMP; experience in Class D and C cleanrooms is advantageous.
  • Good knowledge of hygienic work practices; sterile work under cGMP is advantageous.
  • Technical understanding of production equipment and processes; experience with single-use technologies is advantageous.
  • Ability to work reliably and accurately, independently and as part of a team, and to document work.
  • Good written and spoken German; English is advantageous.
  • Good computer skills, particularly Microsoft Office; experience with SAP and LIMS is advantageous.
  • Availability for weekend work; no night shifts are required.

Responsibilities

  • Manufacture vaccines in upstream cell culture.
  • Prepare, operate, and clean process equipment, including bioreactors, shaking incubators, and centrifuges.
  • Perform and document production activities, including line clearance in vaccine manufacturing, in accordance with guidelines, standard operating procedures, and cGMP quality requirements.
  • Work in a cleanroom up to Class C.
  • Document and perform in-process controls and evaluate their results.
  • Clean, manage, maintain, and service rooms, facilities, and equipment.
  • Support continuous improvement of processes and documents.
  • Assist with material management in production rooms.

About the Company

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
1994

Recently Posted Jobs

Explore more opportunities at Bavarian Nordic

See more jobs